“…Given the metabolic hallmark of the new definition of MAFLD, it could be speculated that an increased risk of cardiovascular complications should be expected in this subtype of NAFLD [37]. Indeed, despite data about cardiovascular abnormalities in MAFLD are limited, it has been showed that individuals with MAFLD phenotype had a substantially increased ASCVD risk compared to those without MAFLD [38].…”